Product
Ezetimibe + Atorvastatin Placebo
1 clinical trial
2 indications
Indication
HypertensionIndication
HypercholesterolemiaClinical trial
A Randomized, Double-blind, Multi-center, Phase III Trial to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary HypercholesterolemiaStatus: Recruiting, Estimated PCD: 2024-06-01